OIG Suggests Lowering Medicare Reimbursement for More Part B Drugs

View Article
CMS could have saved an additional $2.9 million in 2017 if the agency lowered Medicare reimbursement for more Part B drugs through price substitution, the HHS Office of the Inspector General (OIG) recently reported.